8-K//Current report
MoonLake Immunotherapeutics 8-K
Accession 0001213900-24-051263
$MLTXCIK 0001821586operating
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 4:40 PM ET
Size
273.7 KB
Accession
0001213900-24-051263
Documents
- 8-Kea0207582-8k_moonlake.htmPrimary
CURRENT REPORT
- EX-99.1ea020758201ex99-1_moonlake.htm
PRESS RELEASE, DATED JUNE 10, 2024
- GRAPHICimage_001.jpg
GRAPHIC
- GRAPHICex99-1_001.jpg
GRAPHIC
- EX-101.SCHmltx-20240610.xsd
XBRL SCHEMA FILE
- EX-101.LABmltx-20240610_lab.xml
XBRL LABEL FILE
- EX-101.PREmltx-20240610_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-24-051263-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0207582-8k_moonlake_htm.xml
IDEA: XBRL DOCUMENT
Issuer
MoonLake Immunotherapeutics
CIK 0001821586
Entity typeoperating
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001821586
Filing Metadata
- Form type
- 8-K
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 4:40 PM ET
- Size
- 273.7 KB